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Available online 24 August 2016Background: Protractedmethamphetamine (MA) use is associated with decreased control over drug craving and
altered brain volume in the frontostriatal network.However, the nature of volumetric changes following a course
of psychological intervention for MA use is not yet known.
Methods: 66 males (41 MA patients, 25 healthy controls, HC) between the ages of 18–50 were recruited, the MA
patients from new admissions to an in-patient drug rehabilitation centre and the HC via public advertisement,
both in Cape Town, South Africa. 17 MA patients received 4 weeks of treatment as usual (TAU), and 24 MA pa-
tients completed TAU plus daily 30-minute cognitive training (CT) using an N-backworking memory task. Mag-
netic resonance imaging (MRI) at baseline and 4-week follow-up was acquired and voxel-based morphometry
(VBM) was used for analysis.
Results: TAU was associated with larger bilateral striatum (caudate/putamen) volume, whereas CT was associat-
edwithmorewidespread increases of the bilateral basal ganglia (incorporating the amygdala and hippocampus)
and reduced bilateral cerebellum volume coinciding with improvements in impulsivity scores.
Conclusions:While psychological intervention is associatedwith larger volume inmesolimbic reward regions, the
utilisation of additional working memory training as an adjunct to treatment may further normalize
frontostriatal structure and function.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Protracted methamphetamine (MA) use is associated with craving,
risky behaviour and executive dysfunction (Dean et al., 2015;
Mahoney et al., 2015; Semple et al., 2011) as well as deﬁcits in self-reg-
ulatory control (Baicy and London, 2007; Morales et al., 2015). Howev-
er, little is known about the structural brain changes associated with
psychological interventions and adjuncts to treatment such as working
memory (WM) training that together aim to improve neuropsycholog-
ical deﬁcits in those with MA use (Brooks, 2015). The frontostriatal cir-
cuitry is associatedwithWM function (Brooks, 2015; Ersche et al., 2012;atry and Mental Health, Groote
uth Africa.
Brooks),
a@me.com (S.A. Maiorana),
.se (H.B. Schioth),
wc.ac.za (K. Kamaloodien),
. This is an open access article underDahlbomet al., 2009;Gromanet al., 2013) and is impaired followingMA
exposure in prenatally exposed children (Kwiatkowski et al., 2014), ad-
olescents (Lyoo et al., 2015) and adults (Morales et al., 2015). MA adult
users typically have smaller prefrontal cortex and larger striatal vol-
umes (Morales et al., 2012; London et al., 2014), which may reﬂect do-
pamine-related neurotoxicity (Morales et al., 2015). In line with this,
MA use is associated with reduced striatal dopamine transporter
(DAT) and receptor availability (Morales et al., 2015; Ballard et al.,
2015; Yuan et al., 2015). There is also some evidence that molecular al-
terations in the striatum involving inhibited expression of brain derived
neurotrophic factor [BDNF] and dopamine D2 receptor levels may occur
following MA use (Thompson et al., 2015). Such molecular alterations
may present as altered brain volume, which in turn may be associated
with difﬁculties faced by standard psychological interventions to curtail
prevailing high rates of attrition and relapse (London et al., 2014;
Plüddemann and C.D.H, 2012; Panenka et al., 2013).
Abstinence from MA acutely increases caudate and putamen and
decreases prefrontal cortex volumes in MA dependent individualsthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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with microglial and other neural processes involved in rapid
reorganisation prior to neurogenesis (Nixon et al., 2008), and also
with the risk of relapse. However, the inﬂuence of psychological inter-
vention on brain processes in contrast to abstinence alonemay differen-
tially alter brain volume, but this is not yet known. For example, it is not
known whether there is larger or smaller volume in the frontostriatal
circuitry following treatment to reﬂect alterations in neurotoxicity, DA
transporter (DAT) levels, receptor regulation or reorganisation of re-
gional brain networks. Thus, by examining how psychological interven-
tion and adjunctive WM training (associated with frontostriatal
function (Brooks, 2015; Ersche et al., 2012; Dahlbom et al., 2009;
Groman et al., 2013)) alters brain volume it might be possible to isolate
the neurobiologicalmarkers associatedwith treatment efﬁcacy. Psycho-
logical interventions aim to alter neural processes and enhance prob-
lem-solving, self-representation and affect regulation. For example,
greater prefrontal cortex and lesser limbic activation has been reported
following cognitive behavioural therapy treatment for anxiety disorders
(Brooks and Stein, 2015), which are often comorbid with SUD (Harro,
2015). It is pertinent to consider here that the most common factors
for relapse and attrition in those who use MA are poor attention and
risky decision making (Chen et al., 2015), which is associated, in part,
with dysfunction in the frontostriatal network (Kohno et al., 2015)
and concomitantly deﬁcits in WM.
Against this background, our group has recently shown that cogni-
tive training (CT) with a WM task improves self-reported impulsivity
and self-regulation in thosewithMAuse (Brooks et al., n.d.). To progress
this work, herewe examinewhether the same CT as an adjunct to treat-
ment as usual (TAU) alters brain volume in patients receiving treatment
for MA use. Additionally, we aim to examine how brain changes are as-
sociated with improvements in impulsivity and self-regulation.
To aid the formulation of our hypotheses we referred to a recent
meta-analysis of WM training in both HC and patients with schizophre-
nia that demonstrated that greater activation incorporating fronto-pari-
etal networks, the DLPFC and anterior cingulate (ACC), as well as the
striatum, are associated with neuroplasticity changes (Li et al., 2015).
Furthermore, CT is consistently reported to improve cognitive function
in those with psychosis (Keshavan et al., 2014) and attention deﬁcit hy-
peractivity disorder (ADHD) (Klingberg, 2010; Shinaver et al., 2014;
Spencer-Smith and Klingberg, 2015), which are highly comorbid with
regular MA use (Harro, 2015; Hides et al., 2015) and so CT is relevant
for our study population. While the transferability of CT to general cog-
nitive improvement is debated, speciﬁc training that targets localised
brain regions and functions might be most effective for those with MA
dependence (Karbach and Unger, 2014). Moreover, frontostriatal cir-
cuitry, as well as parietal, insula and cerebellar activation is associated
with WM function, as demonstrated in a term-based search (“working
memory”) of the ‘neurosynth’ database (http://www.neurosynth.org/
analyses/terms/), yielding over 900 fMRI studies of WM, which addi-
tionally aided the formulation of our hypotheses. WM supports the
management of distracting internal representations (Brooks, 2015;
Chudasama and Robbins, 2006), such as drug craving and attention to
drug paraphernalia. Thus, speciﬁcally utilising a WM task as an adjunct
to treatment has the potential to strengthen neural processes involved
in self-regulation in the presence of distractors in those being treated
for MA use.
WM training lowers impulsivity in those with substance use disor-
ders (Brooks, 2015; Brooks et al., n.d.; Bickel et al., 2011), and improves
attention in those with attentional deﬁcits and the general public, with
the current leader in the ﬁeld of attentional deﬁcits being CogMed™
(Klingberg, 2010; Spencer-Smith and Klingberg, 2015). However, the
CogMed™ package was not implemented during this study because it
utilises a selection of WM tasks, whereas our task utilises one task,
and we considered that it may be more beneﬁcial, manageable within
treatment schedules and less anxiety-provoking for the patients to
focus on oneWMtask that activates a speciﬁc brain region. For example,in a meta-analysis of 24 functional magnetic resonance imaging (fMRI)
studies using the N-back task, the frontostriatal circuitry is typically ac-
tivated (Owen et al., 2005), whereas it is not yet entirely clear which
distinct brain regions are activated by CogMed. Therefore, for this
study we have used our own modiﬁed WM training based on the N-
back task called ‘Curb Your Addiction (C-Ya)’for CT intervention during
TAU. Finally, while fMRI studies have demonstrated that WM training
alters brain function in the prefrontal cortex corresponding to occupa-
tional changes after 6 months in adults with schizophrenia for example
(Subramaniam et al., 2014), with one fMRI study underway in 7 year-
old children born preterm using CogMed™ (Pascoe et al., 2013), there
has beenno evidence to date regardingpotential structural brain chang-
es associated with WM training in adults who use MA.
Thus, as well as measuring the effects of abstinence during standard
psychological intervention on brain volume in patients being treated for
MA dependence we have additionally examined the effects of adjunc-
tive CT using an N-back WM task. Our aim was to measure how brain
volume is altered by standard psychological TAU, and whether adjunc-
tive CT is associated with additional brain changes. We also explored
whether brain changes are related to changes in impulsivity, self-regu-
lation and mood. Thus, against the research background presented
above, our hypotheses are that: a) smaller frontal and larger striatal vol-
umes in MA using patients at baseline (e.g. at the beginning of treat-
ment) will correspond with higher impulsivity and lower self-
regulation scores; b) by comparison to TAU, the CT group at 4-weeks'
follow-up will have altered frontostriatal volumes corresponding to
greater improvements on impulsivity and self-regulation measures.
2. Methods and materials
2.1. Participants
66 males between the ages of 18–50 were recruited for the study
from January 2013 to September 2014 in Cape Town, South Africa. In-
patients had a history of MA use (n= 41) and attended a local rehabil-
itation clinic. SUD by way of MA use was measured ﬁrstly at clinical in-
terview by qualiﬁed psychologists, and secondly during the study phase
by a qualiﬁed psychiatrist who administered the Structured Clinical In-
terview for Diagnosis (SCID) [see below]. Healthy controls (HC, n= 25)
were local members of the public matched by age and gender. Selection
of the MA use group was conducted via admission lists by clinicians in
the secondweek of admittance to the in-patient facility. Most common-
ly in-patients were polysubstance users, or other primary substance
users such as heroin or cocaine, and so researchers were required to
wait for a potential participant whose primary substance of use was
MA, identiﬁed by the clinical staff. Upon identiﬁcation of a potential par-
ticipant, the study was summarized to the patient by the lead clinician
based on an information leaﬂet provided by the research team. Follow-
ing this a researcher took informed consent and the study procedures
commenced. The study for bothMA users and HC beganwith a SCID in-
terview by a qualiﬁed clinical researcher to conﬁrm primary drug use,
other comorbidities (e.g. anxiety, depression) and smoking status. Par-
ticipants were excluded from further study procedures at this stage if
they did not meet the inclusion/exclusion criteria as described below.
The average duration of MA use in our participants prior to admission
was 9.69 (s.d. 3.8) years – although an accurate average amount of
drug taking could not be ascertained as most patients did not know ex-
actly when they started consuming MA. All in-patients, while recent
users of MA, were abstinent for two weeks (conﬁrmed by clinicians
via urine sampling at the clinic) when commencing our study. The MA
group at baseline was divided (alternated in the order that they were
admitted to the clinic) into two groups by the researcher: those who
would receive TAU (n = 17) and those who would additionally to
TAU receive a CT WM intervention (n = 24) as described below. At
baseline, participants completed a battery of validated psychological
questionnaires to determine levels of self-reported impulsivity, self-
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self-control: at the clinic if in the MA group, and at the university re-
search ofﬁces if in the HC group. At a 4-week follow-up session the
TAU and CT groups repeated the same questionnaire battery.
Of these participants, several were excluded prior to analyses due to
failure to meet inclusion/exclusion criteria, inadequate scan quality,
participant drop-out prior to follow-up and equipment failure at the
scanner to record the log ﬁle. See Supplementary CONSORT diagram.
Inclusion/exclusion criteria for the MA group were: a) MA was the
primary substance of use; b) no history of alcohol use/dependence, al-
though participants were permitted to have concomitant cannabis/
methaquolone use and/or infrequent alcohol use (as determined by
clinical screening); c) no current or previous history of psychosis as con-
ﬁrmed by clinical staff at an admission interview and by researcher in-
terview; d) no prescribed medication during the study.
Inclusion/exclusion criteria for the HC group were: a) no history of
substance or alcohol use disorder, b) no history of an Axis I DSM-IV psy-
chiatric diagnosis, c) no previous neurological condition.
All participantswere required to beﬂuent in English, to be left-hand-
ed and to have a negative HIV diagnosis, as clariﬁed by clinical staff. At
the end of their participation, all participants at baseline received
R150 (South African currency, approximately equivalent to $10) in
food vouchers and the MA group who completed the 4-week follow-
up (e.g. TAU or CT) received an additional R150 food vouchers. The
study adhered to guidelines as set out in the Declaration of Helsinki,
and was approved locally by the University of Cape Town Human Re-
search Ethics Committee (Ref: 554/2012).
2.2. Clinical setting
Patientswere recruited from an in-patient rehabilitation clinic in the
Cape Town area that houses a maximum of 40 patients (male and fe-
male). The programme at the clinic ran over 8 weeks, during which
time patients were provided with 6 meals a day up to 3500 cal,
consisting of a large meal at breakfast, supper, lunch and 3 snacks.
TAU at the clinic involved 1 h sessions (on each weekday) of dialectical
behavioural therapy (DBT) for 6 weeks/30 h at the clinic. DBT is a form
of cognitive-behavioural therapy with more emphasis on addressing
maladaptive affect regulation, and has demonstrated success in treating
substance use disorder (Shearin and Linehan, 1994). Typically, DBT pro-
vides skills training in a group, during individual therapy, via telephone
coaching and as part of a therapist consultation team. There are normal-
ly 4 sets of behavioural skills taught during DBT, namely a)mindfulness,
b) distress tolerance, c) interpersonal effectiveness and d) emotion reg-
ulation. Greater WM capacity is associated with heightened cognitive
control and affect regulation and/or suppression (Brooks, 2015) and
therefore WM training is a useful adjunct to DBT that attempts to im-
prove such skills. Additionally, patients attended daily group sessions,
psychotherapy, basic skills development and both physical and leisure
activities.
2.3. CT group – working memory (WM) training using “Curb Your Addic-
tion (C-Ya)”computerized task
In addition to TAU, the CT group received training in a classroom at
the clinic, using a computer basedWM task called “Curb Your Addiction
(C-Ya)” that was developed by the authors with Fontera Digital Works
(www.fontera.com). Copies of the software are available upon request
(http://www.drsamanthabrooks.com). C-Ya is a modiﬁed version of
the N-back task (themodiﬁcation being a distracting peripheral mosaic
to mimic peripheral distraction in real life), and for the training in the
present study we used standard levels 0-back through to 3-back. The
N-back task was originally introduced by Kirchner (1958) and requires
a response to a speciﬁed target letter as single letters appear on the
screen consecutively. In the present study the letter ‘X’ was the target
for ‘0-back’; the target for ‘1-back’ was when the current letter wasthe same as the ‘1 before’; the target for ‘2-back’was when the current
letter was the same as ‘2 before’ and ‘3 before’ for ‘3-back’. Targets were
identiﬁed by pressing the space bar on the computer keyboard. During
our standard version of the C-Ya task participants begin by completing
30min of 0-back and they progress the next day on to the consecutively
higher level after achieving at least 80% accuracy on the prior level. An
80% threshold was set for our study because in a previous publication
that documented the effects of WM training on neural function the
highest level of accuracy attained was 80%. Therefore, we decided to
use this as a guideline for participant progression through the levels in
our study (Olesen and Westerberg, 2003). Accuracy was calculated
using the following algorithm:
[1− ((number of commissions+ number of omissions) / total pos-
sible correct)] × 100 (Miller et al., 2009), where commissions were re-
sponses to non-target letters; omissions were failures to respond to a
target, and total possible correct were the total target letters.
Participants in this studywere required to engage in the task 5 times
a week for 4 weeks (maximum 20 sessions). WM accuracy on the ﬁrst
and last CT day before the baseline and follow-up scan respectively
was recorded to linkWMfunction to brain volume changes during anal-
yses as described below.
2.4. Questionnaire measures
2.4.1. Structured clinical interview for diagnosis of Axis I DSM-IV disorders
(SCID-IV, (First et al., 2002)– patient version with psychotic screen, and
non-patient version)
We selected patients who were identiﬁed by clinical staff to attend
an interview with a researcher using the SCID for DSM-IV, which was
conducted at the clinic by a qualiﬁed research scientist. For the HC
group the SCID was conducted at the university research ofﬁces. The
SCID included screening questions for substance abuse (including alco-
hol and other drugs), mood, thought, anxiety and general screening
questions.
2.4.2. Hospital anxiety and depression scale (HADS)
The HADS is a 14-item questionnaire used to assess patients' levels
of anxiety and depression (Zigmond and Snaith, 1983). 7 of the items
relate to depression, 7 to anxiety. Items are rated on a 4 point scale,
with a maximum score of 21 for both anxiety and depression. A score
of 0–7 is ‘normal’, 8–10 is ‘borderline’ and 11 or higher is considered
signiﬁcant.
2.4.3. Barratt impulsivity scale (BIS)
The BIS is a 30-item questionnaire designed to assess an individual's
impulsiveness (Patton et al., 1995). Items are scored on a four-point
scale (rarely/never, occasionally, often, almost always/always) to give
6ﬁrst order factors (attention,motor, self-control, cognitive complexity,
perseverance and cognitive instability) and 3-second order factors (at-
tentional, motor and non-planning).
2.4.4. Self-Regulation Questionnaire (SRQ)
The SRQ is a 63-itemquestionnaire designed to assess an individual's
self-regulatory processes (Brown et al., 1999), measuring 7 factors of
self-regulation: a) receiving relevant information, b) evaluating infor-
mation and comparing it to norms, c) triggering change, d) searching
for options, e) formatting a plan, f) implementing the plan and g)
assessing the plan's effectiveness. Items are scored on a 5-point scale
(strongly disagree, disagree, unsure, agree, strongly agree) and partici-
pants are asked to respond based on howwell each statement describes
them. It has been veriﬁed to give good internal consistency and reliabil-
ity in a sample of young adults (Carey et al., 2004).
2.4.5. Visual analogue scale (VAS)
The VAS is a psychometric response scale, used to assess subjective
feelings (Tombaugh, 2004). In this study mood, desire for drug and
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amark on a horizontal line to indicate their current feelings. The left end
point of the line represents lowmood, no desire for drug and no feelings
of self-control, and the right end point represents high mood, high de-
sire for drug and high feelings of self-control respectively. The position
of the mark on the line was measured and transformed into a percent-
age for analysis purposes.
2.4.6. Trail making test (TMT)
The TMT is a paper-based neuropsychological measure of an
individual's speed of processing, mental ﬂexibility, executive function
(e.g. working memory) visual searching and scanning abilities (Reips
and Funke, 2008). The TMT consists of two parts; TMT-A and TMT-B.
TMT-A requires participants to draw a line between 25 numbers evenly
distributed on a piece of paper. TMT B instead requires participants to
alternatively join numbers with letters (e.g. 1, A, 2, B, 3, C). The time
taken to complete the task and the number of errors are recorded. To ac-
count for dexterity the results from TMT-A are subtracted from the re-
sults of TMT-B to produce a ﬁnal score. We used this task to examine
near transfer effects of WM training during the study.
2.4.7. Working memory accuracy
Each participant played Curb Your Addiction (www.
drsamanthabrooks.com) for 12 min (alternating between 6 min of 0-
back and 6min of 1-back) to gauge basic competency on the task during
the experimental procedures. Commission and omission errorswere re-
corded to a log ﬁle and accuracy was calculated according to the algo-
rithm described above.
2.5. MRI data acquisition and pre-processing
For the MRI scans a 1.5 Tesla Siemens Magnetom Allegra scanner
with a 4-channel SENSE head coil was used. Subjects were imaged
with a sagittal T1 weighted image, with 3.82 ms repetition time (TR),
4.74 ms echo time (ET), 90° ﬂip angle, acquisition matrix size
200 × 200 × 200, 3 mm acquisition voxel size, 36 contiguous slices
and slice thickness 3.5 mm. The nifti-converted T1-weighted images
were ﬁrst manually reoriented along the AC-PC plane and examined
for adequate scan quality. Two participant scans were excluded for
poor quality.
For cross-sectional (HC versus MA baseline) and the longitudinal
(repeated measures baseline versus follow-up in the TAU and CT
group) analyses, we used the VBM-8 module of the StatisticalTable 1
Demographic variables.
Demographic variables Groups
Healthy control (n =
21)
All baseline MA (n =
36)
Ba
15
Age (mean, s.d.) 27.67 (8.714) 28.42 (6.129) 29
Type of drug taken (%)
Methamphetamine – 36 (100) 15
Mandrax/dagga/marijuana/nicotine 36 (100) 15
Duration drug taking (yrs) – 9.69 (3.8) 10
Ethnicity, n (%)
Black 7 (33) 1 (3) 1
Mixed-race 2 (10) 34 (94) 13
White 12 (57) 1 (3) 1
Education, n (%)
No matric 1 (5) 23 (64) 9
Matric 1 (5) 13 (36) 6
Undergraduate 12 (57) 0 0
Honours 4 (19) 0 0
PhD 3 (14) 0 0
HC = healthy controls; MA= baseline methamphetamine dependent group; TAU= treatmen
⁎⁎ Chi-squared test of frequency distribution.Parametric Mapping software package SPM (http://www.ﬁl.ion.ucl.ac.
uk/~john/misc/VBMclass10.pdf). For the cross-sectional analyses, indi-
vidual T1 images were ﬁrst aligned to a T1 template in Montreal Neuro-
logical Institute (MNI) space and subsequently segmented into grey
matter, white matter and cerebro-spinal ﬂuid. The grey matter images
were normalized using the diffeomorphic image registration algorithm
(DARTEL) (Ashburner, 2007) and modulated with the nonlinear trans-
formation parameters as computed during the normalization proce-
dures. Subsequent images contain the volume proportion of
probabilistically assigned grey matter tissue for each voxel. These grey
matter probability maps were visually inspected using the display func-
tion in SPM8 and ﬁnally smoothedwith an 8-mmGaussian kernel. Note
that each image of the regional grey matter volume was corrected for
individual brain size as per the VBM8 toolbox pipeline.
For the repeated measures analyses (baseline and follow-up in TAU
and CT groups), MRI data processing was performed using the VBM8
longitudinal batch, which has speciﬁc preprocessing steps for repeated
measures data. These steps are summarized below. Firstly, the follow-
up image was registered to the baseline image for each participant in
each group (TAU, CT). Secondly, the mean image was calculated from
the realigned images for each participant, and this was used as a refer-
ence image for the subsequent spatial alignment. Thirdly, the realigned
images were corrected for ﬁeld inhomogeneity in relation to the refer-
ence mean image. Fourthly, tissue segmentation was performed in the
bias-corrected mean reference image and the bias-corrected realigned
images using the default MNI template. Fifthly, DARTEL spatial normal-
ization parameters were estimated using the tissue segments (grey
matter and white matter) of the bias-corrected mean reference image.
Sixthly, normalization parameters were applied to the tissue segments
of the bias-corrected realigned images. Finally, the resulting normalized
tissue segments for each time point of each participant were smoothed
with an 8-mm Gaussian kernel. To avoid possible edge effects between
grey andwhitematter, all voxels with greymatter values b0.1 were ex-
cluded using the absolute threshold masking option available in SPM8.
2.6. Statistical analyses
Normal distribution was examined with Shapiro-Wilks test and by
examining boxplots. Parametric or non-parametric analyses were ap-
plied accordingly. The assumption of homogeneity of variance was
assessed using Levene's test, and the Welch-Satterthwaite method
was used for all measures where equal variances were not assumed in
order to adjust the t-score and p-value.Statistic
(p-value)
(d = Cohen's effect size)
seline TAU (n =
)
Baseline CT (n =
21)
HC vs. all baseline
MA
Baseline TAU vs.
baseline CT
.00 (6.291) 28.00 (6.132) 0.381 (0.705) 0.477 (0.636)
(100) 21 (100) – –
(100) 21 (100)
.73 (3.955) 8.95 (3.556) – 1.414 (0.166)
⁎⁎ ⁎⁎
(6.5) 0 (0) 41.155 2.965
(87) 21 (100) (b0.001) (0.227)
(6.5) 0 (0)
⁎⁎ ⁎⁎
(60) 14 (67) 48.891 0.169
(40) 7 (33) (b0.001) (0.681)
0
0
0
t as usual; CT = cognitive training; p-value = probability value; n = number.
Table 2
Neuropsychological variables between groups.
Neuropsychological
variables
Groups
mean (s.d)
T statistic
(p-value)
(d = Cohen's effect size)
Healthy
control (n
= 21)
All baseline
MA (n =
36)
Baseline
TAU (n =
15)
Baseline
CT (n =
21)
Follow-up
TAU (n =
13)
Follow-up
CT (n =
15)
HC vs. all
baseline
MA
Baseline TAU
vs. baseline
CT
HC vs.
follow-up
TAU
HC vs.
follow-up
CT
Follow-up TAU
vs. follow-up
CT
Mood (%) 63.9 (14.1) 57.1 (26.7) 55.5 (29.1) 58.2
(25.5)
60.1 (24.4) 75.3 (20.4) 1.267
(0.357⁎)
(0.3)
0.285
(0.704⁎)
(0.1)
0.583
(0.933⁎)
(0.21)
1.864
(0.119⁎)
(0.69)
1.795 (0.142⁎)
(0.71)
Desire for drug (%) 3.8 (6.7) 15.3 (19.5) 13.9 (22.6) 16.3
(17.6)
13.6 (15.8) 9.6 (18.2) 3.210
(0.001⁎)
(0.73)
0.360
(0.374⁎)
(0.12)
2.109
(0.038⁎)
(0.92)
1.343
(0.491⁎)
(0.47)
0.610 (0.339⁎)
(0.24)
Feelings of
self-control (%)
83.7 (14.2) 71.6 (19.9) 69.9 (19.5) 72.9
(20.5)
76.7 (19.6) 89.0 (12.7) 2.433
(0.018)
(0.68)
0.429
(0.547⁎)
(0.15)
1.197
(0.240)
(0.44)
1.149
(0.161⁎)
(0.4)
1.929 (0.098⁎)
(0.79)
Trail making errors
(B-A)
0.5 (0.6) 0.6 (0.9) 0.6 (1.0) 0.5 (0.8) 0.2 (0.7) 0.5 (0.9) 0.333
(0.741)
(0.13)
0.242 (0.811)
(0.12)
1.153
(0.258)
(0.48)
0.149
(0.882)
(0)
0.975 (0.339)
(0.38)
Trail Making RT
(B-A)
32.9 (14.9) 58.2 (37.4) 54.7 (41.3) 61.1
(35.0)
37.8 (31.4) 57.4 (24.4) 3.296
(0.002)
(0.83)
0.452 (0.655)
(0.17)
0.520
(0.610)
(0.22)
3.260
(0.004)
(1.3)
1.783 (0.087)
(0.73)
BIS total 54.5 (8.1) 67.7 (12.1) 68.0 (11.4) 67.4
(12.8)
68.0 (11.2) 60.2 (11.2) 4.625
(b0.001)
(1.24)
0.122 (0.903)
(0.05)
3.881
(0.001)
(1.48)
1.690
(0.101)
(0.62)
1.764 (0.091)
(0.72)
BIS attention 8.9 (2.4) 10.4 (2.5) 10.4 (2.7) 10.5 (2.5) 10.0 (3.1) 9.4 (2.6) 2.247
(0.029)
(0.62)
0.024
(0.796⁎)
(0.04)
1.187
(0.244)
(0.42)
0.605
(0.550)
(0.21)
0.555 (0.584)
(0.22)
BIS motor 14.0 (2.9) 17.2 (4.4) 17.0 (4.7) 17.4 (4.2) 17.4 (4.0) 15.6 (2.2) 3.364
(0.001)
(0.83)
0.259 (0.797)
(0.09)
2.916
(0.006)
(1.04)
1.864
(0.071)
(0.62)
1.493 (0.147)
(0.59)
BIS self-control 10.5 (2.8) 13.5 (3.1) 14.6 (2.6) 12.7 (3.3) 12.4 (3.0) 11.0 (3.6) 3.669
(0.001)
(1.02)
1.839 (0.075)
(0.64)
1.903
(0.066)
(0.68)
0.490
(0.628)
(0.16)
1.096 (0.284)
(0.44)
BIS cognitive
complexity
9.3 (2.4) 11.9 (2.8) 11.9 (2.8) 12.0 (3.0) 11.6 (3.5) 11.3 (2.3) 3.479
(0.001)
(0.99)
0.085 (0.933)
(0.04)
2.283
(0.029)
(0.83)
2.552
(0.016)
(0.87)
0.257 (0.799)
(0.11)
BIS perseverance 6.7 (1.6) 8.6 (2.3) 8.7 (2.4) 8.5 (2.2) 7.9 (2.2) 8.3 (3.3) 3.310
(0.002)
(0.93)
0.268 (0.790)
(0.09)
1.821
(0.080⁎)
(0.67)
1.771
(0.093)
(0.67)
0.380 (0.905⁎)
(0.15)
BIS cognitive
instability
5.0 (1.3) 6.4 (1.5) 6.4 (1.6) 6.5 (1.6) 7.6 (2.1) 5.1 (1.4) 3.465
(0.001)
(1)
0.171
(0.849⁎)
(0.06)
3.948
(0.001)
(1.63)
0.145
(0.658⁎)
(0.08)
3.787 (0.002⁎)
(1.48)
BIS 2nd order
attentional
13.9 (2.3) 16.9 (3.4) 16.8 (3.5) 16.9 (3.5) 17.6 (4.2) 14.5 (3.1) 3.432
(0.001)
(1)
0.105
(0.813⁎)
(0.03)
2.928
(0.009)
(1.21)
0.675
(0.505)
(0.23)
2.275 (0.031)
(0.88)
BIS 2nd order
motor
20.7 (3.7) 25.8 (5.9) 25.7 (6.3) 25.9 (5.8) 25.5 (5.0) 23.9 (4.9) 4.008
(b0.001)
(1)
0.089 (0.930)
(0.03)
3.189
(0.003)
(1.17)
2.290
(0.028)
(0.78)
0.815 (0.423)
(0.34)
BIS 2nd Order
Non-planning
19.8 (4.4) 25.4 (5.2) 26.5 (4.6) 24.7 (5.6) 24.0 (5.9) 22.4 (5.4) 4.119
(b0.001)
(1.16)
1.029 (0.311)
(0.36)
2.366
(0.024)
(0.86)
1.589
(0.122)
(0.55)
0.724 (0.476)
(0.29)
HADS anxiety 6.5 (2.8) 7.8 (2.8) 8.5 (2.0) 7.4 (3.3) 6.4 (2.6) 6.2 (2.2) 1.693
(0.096)
(0.47)
1.235
(0.125⁎) (0.4)
0.108
(0.929⁎)
(0.04)
0.346
(0.835⁎)
(0.12)
0.212 (0.980⁎)
(0.76)
HADS depression 2.4 (2.3) 5.8 (3.3) 5.5 (2.5) 6.0 (3.8) 4.3 (3.0) 3.3 (2.7) 4.640
(b0.001)
(1.16)
0.419 (0.678)
(0.15)
2.095
(0.044)
(0.76)
1.144
(0.261)
(0.76)
0.908 (0.372)
(0.37)
SRQ total 239.8 (13.7) 219.9 (27.8) 214.2
(21.9)
225.7
(32.5)
219.2 (19.4) 241.4
(27.1)
3.084
(0.004)
(0.86)
1.062 (0.299)
(0.23)
3.172
(0.004)
(1.32)
0.195
(0.848)
(0.08)
2.164 (0.043)
(0.97)
SRQ receiving 35.4 (4.3) 30.0 (6.2) 29.4 (5.6) 30.5 (6.6) 30.85 (4.5) 35.5 (6.6) 3.439
(0.001)
(0.98)
0.494 (0.625)
(0.18)
2.907
(0.007)
(1.07)
0.063
(0.704⁎)
(0.02)
2.121 (0.019⁎)
(0.84)
SRQ evaluating 30.2 (3.4) 28.8 (7.9) 30.8 (10.9) 27.2 (3.9) 26.2 (4.0) 26.3 (2.9) 0.781
(0.022⁎)
(0.22)
1.353 (0.185)
(0.49)
3.062
(0.011⁎)
(1.13)
3.533
(0.001)
(1.25)
0.078 (0.938)
(0.03)
SRQ triggering 32.9 (3.1) 31.3 (4.2) 30.9 (3.7) 31.6 (4.6) 31.7 (2.6) 31.4 (3.8) 1.416
(0.163)
(0.42)
0.474
(0.931⁎)
(0.17)
1.039
(0.308)
(0.42)
1.219
(0.232)
(0.45)
0.195 (0.847)
(0.09)
SRQ searching 35.5 (3.8) 36.2 (4.9) 35.6 (4.6) 36.7 (5.2) 35.0 (5.1) 39.4 (3.9) 0.611
(0.544)
(0.16)
0.651 (0.520)
(0.23)
0.283
(0.779)
(0.12)
2.959
(0.005⁎)
(1.04)
2.508 (0.027⁎)
(1.02)
SRQ planning 36.2 (2.3) 28.6 (6.1) 27.5 (5.2) 29.4 (6.7) 30.8 (5.0) 33.7 (7.8) 6.297
(b0.001)
(1.53)
0.827
(0.383⁎)
(0.32)
3.662
(0.002)
(1.56)
1.198
(0.248)
(0.48)
1.153 (0.259)
(0.45)
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Table 2 (continued)
Neuropsychological
variables
Groups
mean (s.d)
T statistic
(p-value)
(d = Cohen's effect size)
SRQ implementing 36.0 (3.0) 31.5 (5.9) 30.5 (4.9) 32.2 (6.7) 33.8 (4.8) 35.7 (7.7) 3.705
(0.001)
(0.91)
0.817 (0.420)
(0.29)
1.639
(0.120⁎)
(0.6)
0.127
(0.950⁎)
(0.06)
0.821 (0.413⁎)
(0.3)
SRQ assessing 35.5 (2.8) 31.1 (5.7) 30.6 (5.4) 31.5 (6.0) 31.5 (4.3) 33.9 (4.1) 3.901
(b0.001)
(0.92)
0.452 (0.654)
(0.16)
3.325
(0.002)
(1.2)
1.403
(0.160⁎)
(0.48)
1.481 (0.155⁎)
(0.59)
Accuracy (%) 48.3
(15.7)
67.1 (10.4)
HC=healthy controls;MA=baselinemethamphetamine dependent group; TAU= treatment as usual; CT= cognitive training; p-value=probability value; n=number; BIS=Barratt
impulsivity scale; HADS = hospital anxiety and depression scale; SRQ = self-regulation questionnaire.
⁎ Mann-Whitney non-parametric post-hoc t-tests were computed due to non-normally distributed data.
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Data analyses were performed using IBM SPSS Software (www.ibm.
com/software/analytics/spss) and Bonferroni corrected for multiple
comparisons. Demographic data was assessed using t-tests and Chi-
squared tests of frequency distribution. All questionnaire measures
were assessed using student t-tests, and for all non-normally distribut-
ed data a Mann Whitney non-parametric t-test was performed. These
were performed between the following groups: HC vs MA baseline,
TAU baseline vs CT baseline, HC vs TAU follow-up, HC vs CT follow-up,
TAU follow-up vs CT follow-up. Further paired sample t-tests were per-
formed on the TAU and CT group between baseline and follow-up to de-
termine the effects of 4weeks of standard treatment. AWilcoxonSigned
Ranks test was performed on all non-normally distributed data. All
measures were Bonferroni corrected according to each individual
questionnaire.
2.8. VBM analyses
All analyses were deemed signiﬁcant at the whole brain, cluster
threshold Family Wise Error (FWE) level. First, a full factorial 2 × 2
ANCOVA (Group × WM Accuracy) was conducted in the total cohort
to examine the main effect of group (HC and MA) and the main effect
of WM accuracy (dichotomised by high/low, split by mean of each
group). Covariates of no interest were age and depression score (due
to its statistically signiﬁcant difference between the groups). We chose
to run the ANCOVA betweenHC andMAbaseline separately, so as to ex-
amine baseline differences, and also given that the HC group was only
scanned once as a normative comparison group. The next repeated
measures ANCOVA was done to examine how TAU and CT alter brain
volume in association to baseline MA.
A second full factorial 3 × 2 ANCOVA (Group × WM Accuracy) was
conducted in all methamphetamine users to examine the main effect
of group (MA, TAU and CT) and main effect of WM accuracy. Covariates
of no interest were age and duration of drug taking (therewas no signif-
icant difference in depression in the MA groups).
Finally, we conducted a 2 × 2 repeated measures ANCOVA to exam-
ine the interaction between group (TAU, CT) and timeline (baseline, fol-
low-up).
3. Results
3.1. Demographic data
See Table 1 for demographic data. There was no signiﬁcant differ-
ence in age between the HC (mean 27.67 years, s.d. 8.714) and total
MA group (mean 28.42 years, s.d. 6.129). However, there were signiﬁ-
cant differences in education (Chi-squared = 48.891, p ≤0.001), with
the HC group reaching graduate level education and the MA groupreaching a highest qualiﬁcation level of matriculation (e.g. University
entrance level). There were also signiﬁcant differences in ethnicity
(Chi-squared=41.155, p ≤0.001),with theHC group beingmostly Cau-
casian, whereas the MA group were predominantly of mixed ancestry.
There was no signiﬁcant difference in age, duration drug taking, educa-
tion or ethnicity between the baseline and follow-up groups and be-
tween the TAU and CT groups. Thus, the baseline MA group was a
robust control group to measure any potential differences at follow-
up, although we included the HC group for measures related to non-
SUD status.
3.2. Questionnaire measures
See Table 2 for between group (HC, MA, TAU, CT) differences.
3.2.1. HC vs baseline MA group
Signiﬁcant differences were found between the HC and BaselineMA
group for the following measures: the MA group had a higher percent-
age desire for drug score (t=3.210, p = 0.001, d = 0.73) a higher trail
making response time (t = 3.296, p = 0.002, d = 0.83) and a higher
HADS depression score (t= 4.640, p ≤0.001, d = 1.16). The MA group
also scored higher on the BIS, including the total score (t = 4.625,
p ≤0.001, d = 1.24), BIS motor (t = 3.364, p = 0.001, d = 1.02), BIS
self-control (t= 3.669, p = 0.001, d = 1.02), BIS cognitive complexity
(t = 3.479, p = 0.001, d = 0.99), BIS perseverance (t = 3.310, p =
0.002, d = 0.93), BIS cognitive instability (t = 3.465, p = 0.001, d =
1.00), BIS second order attentional (t = 3.432, p = 0.001, t = 1.00),
BIS second order motor (t= 4.008, p ≤0.001, d = 1.00) and BIS second
order non-planning (t=4.119, p ≤0.001, d=1.16). They also had lower
self-regulation than the HC group on several subscales of the SRQ, spe-
ciﬁcally receiving (t = 3.439, p = 0.001, d = 0.98), planning (t =
6.297, p ≤0.001, d = 1.53), implementing (t = 3.705, p = 0.001, d =
0.91) and assessing (t= 3.901, p ≤0.001, d = 0.92).
3.2.2. TAU vs. CT at baseline
There were no signiﬁcant differences in any questionnaire measure
between the MA baseline group which became the TAU and CT groups
at follow-up.
3.2.3. HC vs. TAU follow-up
The TAU group had signiﬁcantly higher scores compared to the HC
group on the total BIS (t=3.881, p= 0.001, d=1.48), BIS cognitive in-
stability (t= 3.948, p = 0.001, d = 1.63) and BIS second order motor
(t = 3.189, p = 0.003, d = 1.17). The TAU group also scored lower
than the HC group on several subscales of the SRQ, including total SRQ
(t = 3.172, p = 0.004, d = 1.32), SRQ receiving (t = 2.907, p =
0.007, d = 1.07), SRQ planning (t = 3.662, p = 0.002, d = 1.56) and
SRQ assessing (t= 3.325, p = 0.002, d = 1.2).
Table 3
Baseline vs. follow-up repeated measures within MA group (TAU and CT).
Demographic and psychological
variables
T statistic
(p values)
(d = Cohen's effect size)
Baseline TAU vs.
Follow-up TAU
(n = 13)
Baseline CT vs.
follow-up CT
(n = 15)
Cognitive training accuracy (%) 4.833
(b0.001)
(d = 1.46)
Mood (%) 0.852
(0.311⁎)
(d = 0.18)
2.205
(0.047⁎)
(d = 0.77)
Desire for drug (%) 0.078
(0.939)
(d = 0.02)
1.622
(0.155⁎)
(d = 0.39)
Feelings of self-control 1.025
(0.456⁎)
(d = 0.36)
3.607
(0.003⁎)
(d = 0.98)
Trail making errors (B-A) 1.915
(0.082)
(d = 0.48)
0.318
(0.758)
(d = 0)
Trail making RT (B-A) 2.403
(0.033)
(d = 0.48)
0.257
(0.803)
(d = 0.13)
BIS total 0.781
(0.458)
(d = 0)
2.872
(0.013)
(d = 0.62)
BIS attention 0.356
(0.002⁎)
(d = 0.14)
1.927
(0.099⁎)
(d = 0.45)
BIS motor 0.000
(1.000)
(d = 0.1)
1.822
(d = 0.092)
(d = 0.56)
BIS self-control 2.332
(0.038)
(d = 0.82)
2.071
(0.059)
(d = 0.51)
BIS cognitive complexity 0.090
(0.930)
(d = 0.1)
0.633
(0.538)
(d = 0.27)
BIS perseverance 1.340
(0.179⁎)
(d = 0.36)
0.438
(0.669)
(d = 0.07)
BIS cognitive instability 2.028
(0.067)
(d = 0.67)
2.259
(0.046⁎)
(d = 0.96)
BIS 2nd order attentional 0.285
(0.781)
(d = 0.34)
2.439
(0.045⁎)
(d = 0.75)
BIS 2nd order motor 0.493
(0.632)
(d = 0.04)
1.558
(0.143)
(d = 0.39)
BIS 2nd order non-planning 1.700
(0.115)
(d = 0.49)
1.750
(0.104)
(d = 0.43)
HADS anxiety 1.758
(0.105⁎)
(d = 0.94)
1.046
(0.344⁎)
(d = 0.44)
HADS depression 1.385
(0.194)
(d = 0.45)
2.559
(0.023)
(d = 0.85)
SRQ total 0.121
(0.907)
(d = 0.25)
1.794
(0.116)
(d = 0.54)
SRQ receiving 1.044
(0.317)
(d = 0.3)
2.066
(0.068⁎)
(d = 0.78)
SRQ evaluating 1.705
(0.114)
(d = 0.58)
0.351
(0.732)
(d = 0.27)
SRQ triggering 0.559
(0.475)
(d = 0.26)
0.311
(0.761)
(d = 0.05)
SRQ searching 1.424
(0.185)
(d = 0.13)
2.302
(0.059⁎)
(d = 0.61)
SRQ planning 2.709 2.096
Table 3 (continued)
Demographic and psychological
variables
T statistic
(p values)
(d = Cohen's effect size)
Baseline TAU vs.
Follow-up TAU
(n = 13)
Baseline CT vs.
follow-up CT
(n = 15)
(0.022)
(d = 0.67)
(0.078⁎)
(d = 0.61)
SRQ implementing 2.598
(0.023⁎)
(d = 0.71)
1.981
(0.061⁎)
(d = 0.5)
SRQ assessing 0.386
(0.707)
(d = 0.19)
1.609
(0.194⁎)
(d = 0.48)
HC = healthy controls; MA = baseline methamphetamine dependent group; TAU =
treatment as usual; CT = cognitive training; p-value = probability value; n = number;
BIS = Barratt impulsivity scale; HADS = hospital anxiety and depression scale; SRQ =
self-regulation questionnaire;
⁎ Wilcoxon Signed Ranks non parametric post-hoc t-tests were computed due to non-
normally distributed data.
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The CT group had signiﬁcantly longer trail making response times
compared to the HC group (t = 3.260, p = 0.004, d = 1.3). They also
scored signiﬁcantly lower on several subscales of the SRQ, including
SRQ evaluating (t = 3.533, p = 0.001, d = 1.25) and SRQ searching
(t= 2.959, p = 0.005, d = 1.04). There were no signiﬁcant differences
on any other measures.
3.2.5. Baseline vs. follow-up repeated measures within-group analyses
(TAU and CT)
See Table 3 for difference between baseline and follow-upmeasures.
There were no signiﬁcant differences between baseline and follow-
up in the TAU group at the Bonferroni level. In the CT group, however,
there were improvements in working memory accuracy (t = 4.833,
p ≤0.001, d = 1.41), self-reported feelings of self-control (t = 3.607,
p = 0.003, d = 0.98) and HADS depression (t = 2.559, p = 0.023,
d = 0.85). There were no signiﬁcant improvements on any other
measures.
3.3. VBM analyses
See Tables 4a and 4b for details of all VBManalyses, whichwere FWE
corrected (besides two ﬁndings which were signiﬁcant at the FDR and
uncorrected level respectively, but which we deemed were important
to mention).
The 2 × 2 ANCOVA examining group (HC and baselineMA) andWM
accuracy revealed no signiﬁcant differences in brain volume.
A 3 × 2 ANCOVA examined interactions and any main effect of pa-
tient group (MA, TAU, CT) and of WM accuracy (high, low), correcting
for age and duration of drug taking, FamilyWise Error (FWE) corrected.
See Fig. 1. An interaction in the bilateral putamen extending to the hip-
pocampus (x= 27/−15, y =−16/9, z = 10/−11; cluster size = 801/
1705 voxels; Z statistic = 5.62/5.50; p = 0.001/0.002) and right cere-
bellum (x= 29, y =−85/, z =−33, cluster size = 4172 voxels, Z sta-
tistic = 4.64, p b 0.001) was observed. A main effect of group was
observed in the bilateral putamen extending to the hippocampus
(x=−15/27, y=9/−16, z=−11/10, cluster size=2375/845 voxels,
Z statistic =5.75/5.42, p b 0.001/0.002) and the right caudate (x = 20,
y = 5, z = −11, cluster size = 1301 voxels, Z statistic = 4.69, p =
0.049), left thalamus (x=−17, y-15, z= 10, cluster size= 529 voxels,
Z statistic = 4.60, p = 0.05), bilateral cerebellum (x = 29/−36,
y=−85/−82, z=−33/−30, cluster size=3314/789 voxels, Z statis-
tic = 4.35/3.84, p b 0.001/0.01) and left occipital lobe (x = −23,
y =−97, z =−17, cluster size = 935 voxels, Z statistic = 4.11, p =
485S.J. Brooks et al. / NeuroImage: Clinical 12 (2016) 478–4910.004). A main effect of WM accuracy was observed (although it was a
preliminary ﬁnding as it was only signiﬁcant without FWE correction)
in the right dorsolateral prefrontal cortex (DLPFC) (x = 30, y = 56,
z =−20, cluster size = 155 voxels, Z statistic = 4.10, p = 0.001).
Post-hoc t-tests (all FWE corrected) revealed that the TAU follow-up
group in comparison to baselineMA group had larger volumes in the bi-
lateral putamen extending to the amygdala/hippocampus (x =
27/−15, y =−16/9, z = 10/−11, cluster size = 851/1085 voxels, Z
statistic = 5.56/4.72, p = 0.025/0.009), and the left thalamus
(x =−17, y =−15, z = 10, cluster size = 648 voxels, Z statistic =
4.45, p = 0.036), but no smaller volumes. The CT follow-up group in
comparison to theMAbaseline grouphad larger volumes in the bilateral
putamen extending to the hippocampus/amygdala (x = 20/−15, y =
5/9, z = −11/−11, cluster size = 2134/3619 voxels, Z statistic =
5.66/4.82, p b 0.001/b0.001), right thalamus (x = 21, y = −18, z =
12, cluster size = 746 voxels, Z statistic = 4.68, p = 0.041) and leftTable 4a
3 × 2 ANCOVA group (MA, TAU and CT) × working memory accuracy (high, low), with age an
Brain region MNI coordinates
x y
Interaction
Right putamen (extending to the amygdala/hippocampus) 27 −16
Left putamen (extending to the amygdala/hippocampus) −18 11
Right cerebellum 30 −85
Left cerebellum −29 −54
Main effect of group
Right putamen (extending to the amygdala/hippocampus) 27 −16
Left putamen (extending to the amygdala/hippocampus) −18 11
Left cerebellum −29 −54
Right cerebellum 30 −85
Main effect of working memory accuracy
Right orbitofrontal cortex (Brodmann area 11) 30 56
MA ≥ TAU
Mid orbitofrontal cortex (Brodmann area 11) −2 66
Right cerebellum 21 −87
MA ≥ CT
Right cerebellum 30 −85
Left cerebellum −36 −82
Left orbitofrontal cortex (Brodmann area 11) −29 63
TAU ≥MA
Right putamen 27 −16
Left putamen −18 9
CT ≥MA
Left putamen (extending to the amygdala/hippocampus) −18 11
Right Thalamus (extending to the amygdala/hippocampus) 21 −18
Left Thalamus (extending to the amygdala/hippocampus) −15 −15
Right putamen (extending to the amygdala/hippocampus) 21 6
Left cerebellum −21 −97
Right cerebellum 8 −102
CT ≥ TAU
Left midfrontal gyrus (Brodmann area 6) −24 9
High working memory accuracy ≥ low working memory accuracy
Right orbitofrontal cortex (Brodmann area 11) 30 56
High accuracy MA ≥ TAU
Left cerebellum −50 −63
Right cerebellum 42 −75
High accuracy MA ≥ CT
Right cerebellum 30 −81
High accuracy TAU ≥MA
Right putamen (extending to the amygdala/hippocampus) 27 −16
Left putamen (extending to the amygdala/hippocampus) −20 11
CT high ≥ low accuracy
Right orbitofrontal cortex (Brodmann area 11) 29 57
MNI = Montreal Neurological Institute; FWE= family wise error; TAU= treatment as usual;cerebellum (x=−23, y =−96, z =−24, cluster size = 3841 voxels,
Z statistic = 4.40, p b 0.001), but also smaller volumes in discretely dif-
ferent areas of the bilateral cerebellum (x = 30/−36, y =−85/−82,
z = −35/−30, cluster size = 5135/2649 voxels, Z statistic = 4.57/
4.34, p b 0.001/b0.001).
3.4. WM accuracy (see Fig. 2)
Post-hoc t-tests revealed a preliminary ﬁnding (signiﬁcant only
when not FWE corrected) for larger brain volume in the right DLPFC
in the high versus lowWM accuracy condition regardless of group sta-
tus (x = 30, y = 56, z =−20, cluster size = 221 voxels, Z statistic =
4.25, p b 0.001). Further post-hoc t-tests revealed that highWMaccura-
cy during the scan, after 4 weeks of TAU compared to baseline MA was
associated with smaller bilateral cerebellar volume (x = 51/−50,
y = −47/−63, z = −44/−47, cluster size = 2789/855 voxels, Zd duration drug taking as covariates of no interest.
z Cluster size (Voxels) Z statistic p-Value (FWE clust)
10 457 5.73 0.001
−9 880 5.21 0.004
−35 6111 5.04 0.009
−44 3560 4.96 0.013
10 487 5.61 0.001
−9 1415 5.46 0.001
−44 3912 5.02 0.010
−35 6023 4.96 0.012
−21 54 3.63 0.001
−11 1221 4.07 0.02
−30 1592 3.99 0.007
−35 7516 5.06 b0.001
−30 6056 4.81 b0.001
3 3701 4.27 b0.001
10 510 5.73 b0.001
−9 713 4.58 0.05
−9 1867 5.26 0.003
10 376 4.76 0.02
7 1278 4.12 0.02
−9 1227 4.62 0.02
−24 929 4.32 0.05
−6 1053 4.12 0.03
43 206 4.29 b0.001
−21 90 3.81 b0.001
−47 1150 3.97 0.03
−42 3288 3.90 b0.001
−38 1998 3.92 0.002
10 1845 6.26 0.003
−6 1565 4.47 0.007
−18 438 4.24 0.023
CT = cognitive training; MA =methamphetamine baseline;
Table 4b
2 × 2 ANCOVA group (TAU v CT) and time point (baseline, follow-up).
Brain region MNI coordinates
x y z Cluster
size
(Voxels)
Z
statistic
p-Value
(FWE
clust)
Interaction
Right putamen (extending
to the amygdala)
24 −16 12 1319 7.22 b0.001
Left cerebellum −29 −54 −44 25,009 5.75 b0.001
Left putamen (extending to
the amygdala)
−18 9 −9 3129 5.70 b0.001
Right middle frontal gyrus
(Brodmann area 6)
30 2 57 585 4.93 0.05
Main effect of group
Right middle frontal gyrus
(Brodmann area 6)
30 0 57 923 5.20 0.01
Main effect of time point
Right putamen (extending
to the amygdala)
24 −16 12 1738 7.41 b0.001
Left cerebellum −29 −54 −44 30,060 6.07 b0.001
Left putamen (extending to
the amygdala)
−18 9 −9 4706 6.02 b0.001
Right putamen (extending
to the amygdala)
20 3 −9 1683 5.17 0.014
TAU ≥ CT (regardless of timepoint)
Right middle frontal gyrus
(Brodmann area 6)
30 0 57 1135 5.32 0.021
Left superior frontal
gyrus/SMA (Brodmann
area 6)
−17 −12 63 1079 4.38 0.026
CT ≥ TAU (regardless of timepoint)
Left occipital lobe
(Brodmann area 18)
−6 −88 7 1252 4.12 0.013
Baseline ≥ follow-up (regardless of group)
Left cerebellum −29 −54 −44 35,738 7.23 b0.001
Left middle frontal gyrus
(Brodmann area 6)
−6 44 −9 1343 4.02 0.009
Right middle frontal gyrus
(Brodmann area 6)
8 69 −11 2644 4.02 b0.001
Follow-up ≥ baseline (regardless of group)
Right putamen (extending
to the amygdala)
24 −16 12 9715 7.50 b0.001
Right cerebellum 6 −102 −6 3243 4.81 b0.001
Left cerebellum −23 −100 −21 1117 4.31 0.023
TAU: baseline ≥ follow-up
Left cerebellum −50 −61 −45 7875 5.56 b0.001
Right cerebellum 32 −84 −35 8478 4.44 b0.001
TAU: follow-up ≥ baseline
Right putamen 26 −15 13 966 6.26 0.04
CT: baseline ≥ follow-up
Right cerebellum 32 −85 −36 6756 4.87 b0.001
Left cerebellum −51 −64 −35 4747 4.57 b0.001
CT: follow-up ≥ baseline
Right putamen (extending
to the
amygdala/hippocampus)
22 −18 12 1023 5.69 0.003
Left putamen (extending to
the
amygdala/hippocampus)
−16 6 −9 3033 4.90 b0.001
Right caudate (extending to
the
amygdala/hippocampus)
20 2 −9 1132 4.36 0.021
Baseline: TAU ≥ CT
No signiﬁcant volume
difference
Baseline: CT ≥ TAU
No signiﬁcant volume
difference
486 S.J. Brooks et al. / NeuroImage: Clinical 12 (2016) 478–491statistic = 4.01/3.90, p b 0.001/0.025) and larger bilateral putamen vol-
ume extending to the amygdala/hippocampus (x = −35/27,
y=−7/−16, z=−3/10, cluster size=2527/2757voxels, Z statistic=
6.32/4.51, p b 0.001). High WM accuracy in those patients who addi-
tionally completed WM training was associated with signiﬁcantly re-
duced right cerebellum volume (x = 30, y =−81, z =−38, cluster
size=776 voxels, Z statistic= 3.87, p=0.035) and larger left putamen
(extending to the amygdala/hippocampus) (x=−14, y= 6, z=−14,
cluster size = 1727 voxels, Z statistic = 4.61, p = 0.001). Finally, in the
CT group only, there is preliminary evidence (signiﬁcant without FWE
correction) that high WM accuracy is associated with larger volume in
the right DLPFC (x = 29, y = 57, z =−18, cluster size = 438 voxels,
Z statistic = 4.24, p = 0.023).
A 2 × 2 repeated measures ANCOVA examined interactions and any
main effect of patient group (TAU, CT) and of time point (baseline, fol-
low-up) FamilyWise Error (FWE) corrected. See Fig. 3 and Table 4b. Sig-
niﬁcant interactions were found in the bilateral putamen (extending to
the amygdala) (x = 24/−18, y =−16/9, z = 12/−9, cluster size =
1319/3129 voxels, Z statistic=7.22/5.70, p b 0.001), the left cerebellum
(x =−29, y =−54, z =−44, cluster size = 25,009 voxels, Z statis-
tic = 5.75, p b 0.001) and the right middle frontal gyrus, Brodmann
area 6 (x = 30, y = 2, z = 57, cluster size = 585 voxels, Z statistic =
4.93, p = 0.05). A main effect of patient group was observed, in the
rightmiddle frontal gyrus (x=30, y=0, z=57, cluster size 923voxels,
Z statistic = 5.20, p = 0.01) and a main effect of time point was ob-
served in the bilateral putamen (x = 24/20/−18, y =−16/3/9, z =
12/−9/−9, cluster size = 1738/1683/4706 voxels, Z statistic = 7.41/
5.17/6.02, p b 0.001/0.014) and the left cerebellum (x = −29,
y = −54, z = −44, cluster size = 30,060 voxels, Z statistic = 6.07,
p b 0.001). Subsequent post-hoc t-tests revealed that TAU (regardless
of time point) had larger volume than CT in right middle frontal gyrus,
Brodmann area 6 (x = 30, y = 0, z = 57, cluster size = 1135 voxels,
Z statistic = 5.32, p = 0.021) and left superior frontal gyrus/supple-
mentary motor area (x =−17, y =−12, z = 63, cluster size = 1079
voxels, Z statistic = 4.38, p = 0.026). By contrast the CT group (regard-
less of time point) had larger volume than the TAU group in the left oc-
cipital lobe (x = −6, y =−88, z = 7, cluster size = 1252 voxels, Z
statistic = 4.12, p= 0.013). There was greater volume at baseline com-
pared to follow-up regardless of group, in the left cerebellum (x=−29,
y = −54, z = −44, cluster size = 35,738 voxels, Z statistic = 7.23,
p b 0.001) and the bilateral middle frontal gyrus (x =−6/8, y = 44/
69, z =−9/−11, cluster size = 1343/2644 voxels, Z statistic = 4.02,
p = 0.009/b0.001). Conversely, in the follow-up time point regardless
of group, larger volume compared to baseline was observed in the
right putamen extending to the amygdala (x = 24, y =−16, z = 12,
cluster size=9715 voxels, Z statistic=7.50, p b 0.001) and the bilateral
cerebellum (x = −23/6, y = −102/−100, z = −6/−21, cluster
size = 3243/1117 voxels, Z statistic = 4.81/4.31, p b 0.001/0.023).
In terms of repeated measures group differences, in the TAU group,
we observed larger bilateral cerebellar volumes at baseline compared
to follow-up (x = −50/32, y = −61/−84, z = −45/−35, cluster
size = 7875/8478 voxels, Z statistic = 5.56/4.44, p b 0.001), whereas
at the follow-up timepoint compared to baseline the TAU group had
larger right putamen volume (x = 26, y = −15, z = 13, cluster
size = 966 voxels, Z statistic = 6.26, p = 0.04).
In the CT group at baseline compared to follow-up, we again ob-
served larger bilateral cerebellar volumes (x = 32/−51,
y =−85/−64, z =−36/−35, cluster size = 6756/4747 voxels, Z sta-
tistic= 4.87/4.57, p b 0.001). However, in the follow-up versus baseline
time point there were more protracted larger volumes in the CT group
than were observed in the TAU group, in bilateral putamen (extending
to the amygdala/hippocampus) (x = 22/−16, y = −18/6, z =
12/−9, cluster size = 1023/3033 voxels, Z statistic = 5.69/4.90, p =
0.003/b0.001) and the right caudate (extending to the amygdala/hippo-
campus) (x = 20, y = 2, z =−9, cluster size = 1132 voxels, Z statis-
tic = 4.36, p = 0.021). No other volumetric differences were observed.
Table 4b (continued)
Brain region MNI coordinates
x y z Cluster
size
(Voxels)
Z
statistic
p-Value
(FWE
clust)
Follow-up: TAU ≥ CT
No signiﬁcant volume
difference
Follow-up: CT ≥ TAU
No signiﬁcant volume
difference
MNI = Montreal Neurological Institute; FWE = family wise error; TAU = treatment as
usual; CT = cognitive training; SMA= supplementary motor area.
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This voxel-based morphometry (VBM) study is the ﬁrst to examine
whether 4weeks of standard psychological interventionwith additional
adjunctive working memory (WM) training can alter brain volume in
male in-patients being treated for methamphetamine (MA) use. Addi-
tionally, we sought to link volumetric brain changes to improvements
in subjective self-report measures of impulse control, self-regulation
andWMaccuracy. Itmust benoted that changes in self-reportmeasures
while intriguingmay not transfer to actual changes in clinical measures.
Nevertheless, after 4 weeks of psychological TAU, MA using males ex-
hibited larger volume in the bilateral putamen (extending to the hippo-
campus) and reduced left middle temporal gyrus, right post-central
gyrus and left insula cortex volume. Further, those who had additional
cognitive training (CT) demonstrated more pronounced increases in
volume that extended across large areas of the bilateral basal ganglia,
as well as reduced bilateral cerebellar volume. While no signiﬁcant cor-
relations between questionnaire measures of impulsivity, self-regula-
tion and changes in brain volume were observed, greater
improvements/normalization in impulsivity and self-regulation scoresFig. 1. Interaction in the bilateral striatum and cerebellum. Z= axial plane, colour-bar represen
bilateral putamen differences.were found in the CT compared to the TAU group. This may suggest
that the brain volumetric differences observed may be attributable to
clinical improvements rather than self-reports in the CT group, although
there are likely also other variables at play, such as molecular mecha-
nisms and genetic susceptibility associated with impulsivity. Finally,
we presented some preliminary evidence that greater WM accuracy at
follow-up in the CT group was associated with larger volume in the
right middle frontal cortex and orbitofrontal cortex, regions associated
with executive functioning, WM ability and impulse control (Brooks,
2015). We suggest that with no medications known to improve MA
use disorder reliably and no psychological interventions yet able to ef-
fectively reduce relapse rates, it is important to explore the neurobio-
logical effects of adjunctive behavioural interventions such as WM
training, and so our study provides a useful progression to the ﬁeld.
A recentmeta-analysis of WM training in both HC and patients with
schizophrenia demonstrates that greater activation incorporating
frontoparietal networks, the DLPFC and anterior cingulate, as well as
the striatum, are associated with neuroplasticity changes (Li et al.,
2015). Additionally, previous studies have shown that cerebellar (Ding
et al., 2012), striatum, lateral prefrontal and frontoparietal grey matter
volume alterations are associated with WM capacity (Ruge and
Wolfensteller, 2015), and that larger volume in the lateral prefrontal
cortex is particularly susceptible to variations in WM capacity (Reid et
al., 2015). Furthermore, training using a WM task has been associated
with reductions in frontoparietal network volume (Takeuchi et al.,
2011), although there is some indication that basal ganglia networks
are more susceptible to WM training (Klingberg, 2014). Thus, in line
with previous research, we ﬁnd increases in volume following WM
training that are most signiﬁcant in the basal ganglia, and we show
this for the ﬁrst time in male patients being treated for MA use.
The effects of CT on brain volumemay have been confounded by the
neurotoxic effects of MA exposure, suggesting that longitudinal studies
using CTmay bemore beneﬁcial to clinical advances. Neurotoxic effects
of MA exposure have been shown by animal models to be associated
with reductions in dopamine, serotonin and associated dopaminets the F-statistic. Top row illustrates bilateral cerebellar differences. Bottom row illustrates
488 S.J. Brooks et al. / NeuroImage: Clinical 12 (2016) 478–491transporter (DAT) systems, as well as greater expression of brain de-
rived neurotrophic factor (BDNF) in frontal, parietal, and basal ganglia
areas (Braun et al., 2011). DAT is reduced in rats exposed to MA for
10 days, particularly in the striatum, orbitofrontal cortex, dorsolateral
prefrontal cortex and amygdala, persisting after abstinence (Hong et
al., 2015). Furthermore, animal models have demonstrated that MA ex-
posure impairs spatial learning and memory, (Bigdeli et al., 2015), but
that proactive interference (the tendency to repeat previous responses)
to WM can be ameliorated with a dopamine D1 receptor antagonist
(Macaskill et al., 2015). Additionally, impaired memory in mice that
have been exposed to MA is associated with dysfunction in dopamine
D1 receptor-extracellular signal-regulated kinase 1/2 (ERK1/2) path-
way in the prefrontal cortex, striatum and hippocampus (Nagai and
Yamada, 2010). Thus, animal models of MA exposure and concomitant
WMdeﬁcits consistently report the involvement of disrupted dopamine
activity in the frontostriatal neural circuitry, which is associated with
WM. It might therefore be useful to study the effects of WM training
on neurochemistry in animal models.
Animal studies of WM training support the hypothesis that
frontostriatal circuitry changes coincide with learning and memory.
For example, volume change in the medial striatum in mice is implicat-
ed in spatialWM training (Pooters et al., 2015), and studies have shown
epigenetic effects in the dorsal and medial striatum in mice after WM
training (Cassanelli et al., 2015). Additionally, methylation sequencesa) Main e
accura
(TAU+
b) Larger bilateral basal ganglia 
volume in CT > MA 
R L 
R 
L 
Fig. 2.Highworkingmemory accuracy in the rightmiddle frontal cortex. a)Higherworkingmem
to baseline MA revealed larger middle frontal cortex volume; b) Larger bilateral basal ganglia v
bilateral basal ganglia volume is also observed in the TAU NMA group but the effects are less sin prefrontal cortex neurons of mice are shown to be susceptible to
WM training effects (Jakovcevski et al., 2015). Furthermore, cerebellar
volume (which was shown to be reduced following WM training in
our human cohort) is associated with plasticity-related volume in-
creases duringmotorWM learning inmice (Yamazaki et al., 2015). Sim-
ilarly, activation of dopaminergic circuits (associated with the basal
ganglia in humans) are shown to mediate short and long termmemory
formation associated with reward reinforcement in Drosophila
melanogaster (Yamagata et al., 2015). Moreover, the role of greater
DLPFC activation in delaying the application of recently learned visual
information and of concurrently regulating tactile stimuli is demon-
strated in a recent study of monkeys completing a uni- and cross-
modal visual and haptic perception task (Wang et al., 2015). Thus, ani-
malmodels help to understand the observations of volumetric brain dif-
ferences in patients with MA dependence undergoing CT in our study.
Studies of CT using WM tasks in humans have highlighted that efﬁ-
ciency within neural system operations can be achieved by potentially
fostering inherent plasticity processes (Keshavan et al., 2014;
Subramaniam et al., 2014), particularly in the frontostriatal circuitry
(Haut et al., 2010). This coincides with improved cognitive functioning
in people with ADHD; (Klingberg, 2010; Spencer-Smith and Klingberg,
2015), schizophrenia (Li et al., 2015) and some evidence in those with
substance use disorder (Brooks et al., n.d.; Bickel et al., 2015; Wesley
and Bickel, 2014). For example, computerized WM training has beenL 
L 
R 
R 
ffect of working memory 
cy 
CT > MA) 
c) Basal ganglia volume in TAU > MA 
is less prolific than in CT > MA 
R L 
L 
R 
ory accuracy during the experimental procedure in both the TAUand CT groups compared
olume associated with higher working memory accuracy in the CT NMA group; c) larger
igniﬁcant than in the previous CT NMA contrast.
489S.J. Brooks et al. / NeuroImage: Clinical 12 (2016) 478–491shown to reduce impulsivity and delay discounting (lowering the pref-
erence for immediate over delayed rewards) among stimulant users
(Bickel et al., 2011). Additionally, WM tasks have been shown in a
meta-analysis to activate DLPFC with reduced activation coinciding
with reduced temporal discounting, a measure of impulsivity, in those
with stimulant use disorder (Wesley and Bickel, 2014). However, until
now there has been no brain imaging studies to show thatWM training
alters brain volume associated with underlying functional mechanisms,
in the frontostriatal circuitry in MA dependent individuals.
It is intriguing to consider ﬁndings that abstinence fromMA acutely
increases striatal volume, andmay be a reﬂection of compensatory cog-
nitions that maintain optimal functioning, greater glial activation or in-
ﬂammation associated with MA-related injury (London et al., 2014;
Ballard et al., 2015; Yuan et al., 2015; Nixon et al., 2008; Jernigan et al.,
2005; Chang et al., 2005; Jan et al., 2012). Although longer term psycho-
logical intervention may differentially alter brain volume. It is not yet
clear how interventions for MA use alter brain volume, for example,
whether there is larger or smaller volume in the frontostriatal circuitry
over a period of time to reﬂect alterations in neurotoxicity, DA trans-
porter levels and receptor regulation or reorganisation of regional
brain networks for example. It might be intuitive to expect a reduction
in striatal brain volume following TAU or an adjunctive intervention,
given thatMA users generally exhibit larger striatal grey-matter volume
than non-users (Berman et al., 2008). However, greater striatal activa-
tion associated with neuroplasticity changes have been shown after
CT (Brooks et al., n.d.), which would support our observations here.Baseline >
                    a) Treatment as usual 
Follow-up
                  c) Treatment as usual      
Fig. 3. Repeated measures effects. a) In TAU, baseline N follow-up there was larger bilateral cer
volume; c) in the TAU group at follow-up N baseline there was larger bilateral putamen volum
volumes in the bilateral basal ganglia, extending to amygdala/hippocampus.Nevertheless, the question remains, what else could underlie our ob-
served increase in basal ganglia volume followingWM training in male
in-patients being treated for MA use? It might be that repetitive and in-
creasingly difﬁcult training over 4 weeks encourages inherent neural
plasticity after the initial involvement of neuronal support systems
(e.g. microglia) (Nixon et al., 2008), which forgemore efﬁcient commu-
nication along the frontostriatal circuitry. This in turnmight lead the pa-
tient, during DBT treatment, to have better adherence to cognitive
strategies while regulating affective (interoceptive) and environmental
(exteroceptive) distractors. For example, blunting of negative affect and
drug taking prior to treatment may coincide with a maladaptive coping
approach that helps a person to limit the recollection of traumatic life
experiences. However, the harnessing of daily and increasingly loaded
WM training that fosters inherent neural plasticity (Keshavan et al.,
2014; Subramaniam et al., 2014) associated with larger brain volumes
may reﬂect enhanced basal ganglia connections and better affect regu-
lation. In this vein, recent evidence in humans supports the view that
greater brain volume after a course of WM training may be associated
with myelination and related microstructural markers that underpin
plasticity and improvements in clinical populations (Caeyenberghs et
al., 2016). However, it is not yet clear that if WM training fosters such
neuroplasticity beneﬁts, whether the effects are longer term, and so
more longitudinal studies are needed.
Some limitations deserve consideration during the interpretation of
our ﬁndings. Firstly, we did not observe greater striatal volume in the
MA cohort at baseline, as is extensively reported in humans (London Follow-up 
     b) Cognitive trained 
 > Baseline 
           d) Cognitive trained 
ebellar volume; b) in the CT baseline N follow-up there was also larger bilateral cerebellar
e; d) however, in the CT group at follow-up N baseline there were more signiﬁcant larger
490 S.J. Brooks et al. / NeuroImage: Clinical 12 (2016) 478–491et al., 2014; Jan et al., 2012; Churchwell et al., 2012; Chang et al., 2007).
However, our failure to replicate these well-reported ﬁndings could be
due to our MA cohort being abstinent for at least two weeks at the
start of the study and recovering from malnourishment, which can
alter regional brain volume (Titova et al., 2013), due to re-feeding for
twoweeks. Therefore, neuronal re-wiring due to treatment and re-feed-
ing effects may have already occurred and prevented our replication of
greater striatal volume inMA compared to HC at baseline. Furthermore,
we did not take measures of cytokines in blood that may differentiate
larger brain volume due to neurotoxicity from larger volume due to
neuroplasticity. Secondly, we did not contrast the CT group with a con-
trol MA group that also spent time on a computer and had regular con-
tact with researchers but that did not receive the WM training
intervention. This is pertinent as it could be that regular social interac-
tion with researchers could have led to the volumetric changes we ob-
served. Additionally, the sample was confounded by our inability to
gauge an accurate duration of drug use and length of abstinence prior
to treatment, although all in-patients were drug free for two weeks
from the beginning of the study. Also, we only recruited males since
the in-patient facility at the time of our study housed only males,
preventing generalization to females. Finally, therewas a signiﬁcant dif-
ference in ethnicity and level of education between the HC and MA
group, although we accounted for this by conducting analyses with
the baseline MA group as the control condition for treatment effect,
and also by conducting repeated measures analyses.
In summary, having previously observed that adjunctive WM train-
ing improves outcomes compared to TAU in MA usingmales (Brooks et
al., n.d.), here we extend our work by investigating the potential in-
volvement of speciﬁc brain regions in improved clinical outcomes, and
discuss somepossiblemolecularmechanisms associatedwith the dopa-
minergic reward circuitry. First, using voxel-based morphometry we
demonstrate that daily adjunctiveWMtraining is associatedwith great-
er increases in frontostriatal circuitry than is seen in TAU. Second,we re-
port that in the CT group the neural alterations observed are associated
with improvements in self-reported affect regulation and reduced im-
pulsivity. While further work is needed to investigate the neurobiolog-
ical mechanisms and molecular underpinnings responsible for these
increases in volume, as well as potential longitudinal transfer, these
data are important in buttressing our view that CT may be useful in
those being treated for MA use. We further posit that our data provide
a clear model of the relevant neurocircuitry that underlies the impact
of CT.Conﬂicts of interest
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